RQMIS

Our vision is simple: To be the provider of choice for the development and implementation of regulatory and insurance strategy by utilizing the most efficient and effective commercialization pathway to medical product markets across the globe, including designing the quality system that brings the product to life. When these pathways demand clinical evidence to validate that a product is safe and effective, whether it is for publication, insurance reimbursement or regulatory approval, RQMIS provides our customers with complete support for the entire product lifecycle. Since 1996, RQMIS has been providing manufacturers in the medical and healthcare industries with strategic guidance...

Medical devices,regulatory,clinical,consulting,quality management systems,510(k),fda clearance,eu mdr / ivdr,clinical trial design,eu authorized representative,us agent,audits,fda presubmission,techincal files,clinical evaluation report (cer),regulatory strategy,product classification,insurance reimbursement,post-market surveillence,uk responsible person,de novo,and fda consulting

Rqmis operates in the Business consulting and services industry.

Rqmis's revenue is 11m - 100m

Rqmis has 11 - 50 employees.